Trial intelligence / Profile preview

ctDNA Analysis in Colorectal Cancer

NCT03038217Phase 3Unknown

Sponsor
Peking Union Medical College Hospital
Start
Feb 2017
Primary completion
Dec 2020
01

Overview

Phase 3 trial (4 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Disease Free Survival at 5 years, Local Recurrence at 5 years and 1 more. Status: unknown.

Beyond the preview

Go deeper on NCT03038217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03038217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call